F18 RADIOPHARMACEUTICALS
Archived on July 31, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 4:00 PM EST
- Posted
- April 20, 2026
- Notice type
- Sources Sought
- Set-aside
- No Set aside used
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Office
- 247-NETWORK CONTRACT OFFICE 7 (36C247)
- Place of performance
- Decatur, Georgia, 30033
- Last updated
- Oct 31, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 36C24726Q0232
- Notice ID
- 966695dc01f94c17a259ac23b65c46c1
Description
The vendor shall provide all labor, supervision, and transportation necessary to provide daily delivery of F-18 FDG (fluorodeoxyglucose), NaF-F18 (sodium fluoride), F18- beta-amyloid imaging agent, F18-Axumin (fluciclovine), F18-Tauvid (Floracipir), F18-Cerianna (Fluoroestradiol), F18-Posluma (Flotufolastat), and F18-Pylarify (Piflufolastat) CAIX Radiopharmaceutical, choline PET radiopharmaceuticals and F18-FET to the NM Service, located in the Atlanta Veterans Affairs Medical Center (ATL VAMC), 1670 Clairmont Road, Decatur, GA 30033.
- The vendor shall be an established commercial radiopharmacy that has operated continuously for at least the past 10 years.
- The vendor shall have a system of order/shipment/delivery/return that includes procedures for return of spent (used) syringes that meets the Occupational Safety and Health Administration (OSHA) Biohazardous Waste Policy/Regulations. The system shall be needleless.
- The vendor shall be licensed by the US NRC and/or by an Agreement State to prepare and distribute radiopharmaceuticals. The vendor shall provide the ATL VA HCS a copy of the license and copies of applicable inspection reports
- The vendor shall provide documentation that the cyclotrons used by the vendor are FDA approved for commercial use.
- The vendor shall accept returns for full credit toward future orders with no order charges or return charges when any of the following conditions are valid: 1.product ordered or shipped in error 2. product delivered with visible damage received during shipment 3. product delivered with concealed damage received during shipment 4. product that has been recalled 5. product that is expired and in unopened, original container 6. product that has any mutually agreed upon negative issues that are the result of routine vendor processing
Award Overview
Possible prior contract
Inferred, not confirmedInferred, not confirmed. Matched by agency, NAICS, place of performance and end-date proximity. This is a candidate, not the contractor of record.
Dollar amounts are not shown for inferred matches because the link is heuristic. Open the award below to check it.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
RFI-36C24726Q0232-F18 Radiopharmaceuticals.pdf
111 KBAdded in Sources Sought version 3Posted
Lifecycle
- 3Version 3Sources SoughtArchived
F18 RADIOPHARMACEUTICALS
- 6Version 6Sources SoughtArchivedCurrent
F18 RADIOPHARMACEUTICALS
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C24726Q0232
Archive Date
Jul 31, 2026
Office Address
AUGUSTA, GA, 30904